Skip to main content

CORRECTION article

Front. Endocrinol., 25 July 2024
Sec. Translational and Clinical Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1463390

Corrigendum: Time for micro-RNAs in steatotic liver disease: a case–control study

This article is a correction to:

  1. Time for micro-RNAs in steatotic liver disease: a case–control study

    1. Read original article
Victor Constantin Stoica,*Victor Constantin Stoica1,2*Dimitri ApostolDimitri Apostol2Mihai Mircea Diculescu,Mihai Mircea Diculescu1,3Iuliana Petronela GrdanIuliana Petronela Gârdan4Daniel Adrian GrdanDaniel Adrian Gârdan5Ion M&#x;run&#x;elu,Ion Mărunţelu2,6Ileana Constantinescu,Ileana Constantinescu2,6
  • 1Department of Gastroenterology, Fundeni Clinical Institute, Bucharest, Romania
  • 2Immunology and Transplant Immunology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • 3Department of Gastroenterology, “Carol Davila” University of Medicine and Pharmacy”, Bucharest, Romania
  • 4Department of Psychology and Education Sciences, Spiru Haret University, Bucharest, Romania
  • 5Department of Economic Sciences, Spiru Haret University, Bucharest, Romania
  • 6Center for Immunogenetics and Virology, Fundeni Clinical Institute, Bucharest, Romania

A Corrigendum on:
Time for micro-RNAs in steatotic liver disease: a case–control study

By Stoica VC, Apostol D, Diculescu MM, Gârdan IP, Gârdan DA, Mărunţelu I and Constantinescu I (2024). Front. Endocrinol. 15:1349524. doi: 10.3389/fendo.2024.1349524

In the published article, there was an error in affiliation 4. Instead of Center for Immunogenetics and Virology, Fundeni Clinical Institute, Bucharest, Romania, it should be Department of Psychology and Education Sciences, Spiru Haret University, Bucharest, Romania.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: micro-RNA, NAFLD, MAFLD, fatty liver disease, case-control study

Citation: Stoica VC, Apostol D, Diculescu MM, Gârdan IP, Gârdan DA, Mărunţelu I and Constantinescu I (2024) Corrigendum: Time for micro-RNAs in steatotic liver disease: a case–control study. Front. Endocrinol. 15:1463390. doi: 10.3389/fendo.2024.1463390

Received: 11 July 2024; Accepted: 16 July 2024;
Published: 25 July 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Stoica, Apostol, Diculescu, Gârdan, Gârdan, Mărunţelu and Constantinescu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Victor Constantin Stoica, Y29uc3RhbnRpbi5zdG9pY2FAZHJkLnVtZmNkLnJv

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.